Vibrahealth

Research Notice: Research cited on this page is independent, peer-reviewed scientific work. BGREEN and Turtlegym products are wellness and lifestyle equipment — they are not medical devices and are not intended to diagnose, treat, cure, or prevent any medical condition. Findings from independent research do not constitute claims about Vibrahealth products. Persons with health conditions should consult a qualified healthcare professional before use.

Research Summary

Published research has found that WBV was associated with reductions in arterial stiffness, improvements in blood pressure parameters, and enhanced peripheral circulation in multiple controlled studies. The proposed mechanisms include nitric oxide-mediated vasodilation and improvements in endothelial function triggered by vibration-induced mechanical stimulation. WBV is not a medical treatment for cardiovascular conditions; individuals with diagnosed cardiovascular disease should consult a healthcare professional before starting any vibration programme.

Research at a Glance

Study Year Evidence Type Population Key Finding (as reported)
Chen et al. 2016 Experimental Study Elderly adults WBVV was associated with reduced blood pressure and improved arterial stiffness markers; study conducted using a BodyGreen vertical vibration device
Liu et al. 2021 Randomised Crossover Study Healthy young adults (20–25 years) Low-frequency LBV (15 Hz) was associated with reduced peripheral vascular tone, accelerated HR recovery, decreased sympathetic activity, and increased parasympathetic activity post-exercise

Why This Topic Matters

Arterial stiffness is a primary marker of cardiovascular ageing and an independent predictor of cardiovascular events, stroke, and all-cause mortality. Pulse wave velocity (PWV) — the speed at which pressure waves travel along the arterial wall — is the gold-standard non-invasive measure of arterial stiffness. As arteries stiffen with age, the heart must work harder to pump blood against a less compliant arterial system, contributing to hypertension, left ventricular hypertrophy, and increased cardiac workload.

As Singapore’s population ages, hypertension and arterial disease represent a major and growing burden on individuals and the healthcare system. Conventional aerobic exercise reduces arterial stiffness — the same mechanism engaged by exercise is mediated partly through repeated shear stress on the endothelium, which stimulates nitric oxide (NO) production and vasodilation. However, aerobic exercise is often impractical for frail or mobility-limited older adults.

Researchers have examined whether Whole Body Vertical Vibration (WBVV) — which delivers a mechanical stimulus that increases circulation and muscle pump activity — can produce measurable vascular benefits, specifically whether it is associated with reduced arterial stiffness and improved blood pressure parameters.

Relevant for: Cardiologists and geriatricians · Eldercare and rehabilitation facility managers · Physiotherapists working with hypertensive older adults · Health-conscious older adults · Corporate wellness managers

Research Overview

WBVV research in cardiovascular health spans two related but distinct outcome domains: (1) arterial stiffness and blood pressure in older adults, and (2) post-exercise cardiovascular autonomic recovery in younger adults.

Proposed mechanism: The mechanical stimulus from WBVV increases peripheral circulation and activates the muscle pump, generating shear stress on the vascular endothelium. This shear stress is a known stimulus for endothelial nitric oxide synthase (eNOS) activation — the same enzyme activated by conventional aerobic exercise — leading to nitric oxide (NO) production and vasodilation. This is the same proposed mechanism pathway that connects WBPA to nitric oxide production, though WBPA achieves this through horizontal rocking motion rather than vertical vibration.

Types of studies: experimental acute studies (examining immediate post-vibration changes in vascular tone and blood pressure); multi-session training studies; the 2016 Chen study specifically examined arterial stiffness parameters and blood pressure in elderly adults using a BodyGreen vertical vibration device.

Important distinction from WBPA: Whole Body Periodic Acceleration (WBPA) — delivered by the BGREEN uBed — uses horizontal rocking motion to generate shear stress on the endothelium and has been studied specifically for nitric oxide production and endothelial function. WBVV achieves a similar mechanical stimulus through vertical oscillation. Both technologies are conceptually linked to NO production but through different mechanical pathways.

Key Published Studies

EXPERIMENTAL STUDY2016 · Conference proceedings (ECSS)

Chen et al. — Arterial Stiffness Study

What they examined: Researchers examined whether a 6-week whole body vertical vibration programme could reduce arterial stiffness and lower blood pressure in elderly adults. This is of particular relevance to Singapore’s ageing population, where arterial stiffness is a significant cardiovascular risk factor. In this study, researchers used a BodyGreen vertical vibration device — the same brand as the BGREEN products available in Singapore through Vibrahealth.

What researchers reported: WBVV was associated with reduced blood pressure and improved arterial stiffness parameters in the elderly participants studied, over the 6-week intervention period.

Factual note: This study was conducted using a BodyGreen vertical vibration device. This is stated as a matter of record from the study methodology. The use of the same brand does not constitute a claim that identical outcomes would result from other WBVV products or protocols.

RANDOMISED CROSSOVER STUDY2021 · Journal of Sports Science and Medicine

Liu et al. (2021) — Cardiovascular Autonomic Recovery

What they examined: Researchers examined whether low-frequency lower-body vibration (LBV) could accelerate post-exercise cardiovascular autonomic recovery in 19 healthy young adults (10 men, 9 women, aged 20–25 years). Participants received vibration at 0 Hz (control), 5 Hz, or 15 Hz in a randomised crossover design after a standardised step test. Outcomes measured included heart rate variability (HRV) — including LF/HF ratio and normalised high-frequency power (nHF) — and digital volume pulse (reflection index).

What researchers reported: Under 15 Hz vibration, the reflection index decreased during vibration (indicating reduced peripheral vascular tone). Heart rate decreased during recovery. LF/HF ratio decreased and nHF increased during vibration and recovery under 15 Hz, and during recovery under 5 Hz. Researchers concluded that low-frequency LBV after exercise reduces peripheral vascular tone, accelerates heart rate recovery, decreases cardiac sympathetic nerve activity, and promotes parasympathetic nerve activity — with the effect more pronounced at 15 Hz than 5 Hz.

Note: This study was conducted in young healthy adults (20–25 years). Findings may not directly translate to older adults or clinical populations.

Read the full study →

Connecting WBVV and WBPA for Vascular Health

The proposed vascular benefits of WBVV — mediated through shear stress and nitric oxide production — are conceptually related to the WBPA literature, which has been more specifically focused on this pathway. WBPA (Whole Body Periodic Acceleration), delivered by the BGREEN uBed, uses horizontal rocking acceleration to generate shear stress on the endothelium and has been studied for nitric oxide production in both animal and human studies.

While WBVV and WBPA use different mechanical motions to achieve a similar end result (increased endothelial shear stress and potentially NO production), they represent two distinct vibration technologies. The WBPA and Nitric Oxide Research page covers the body of research specifically focused on this technology pathway.

Methodology Notes

The Chen 2016 arterial stiffness study was conducted in elderly adults using a BodyGreen vertical vibration device. The 6-week protocol and the vascular outcomes measured provide evidence relevant to Singapore’s ageing population. However, this was a conference presentation (ECSS proceedings) — readers should seek the full published paper for complete methodological detail.

The Liu 2021 study was conducted in young healthy adults (20–25 years), which limits generalisability to older or clinical populations. The acute post-exercise design measures immediate autonomic recovery rather than long-term cardiovascular adaptation. The crossover design is methodologically strong for acute studies.

Frequency matters: The Liu 2021 study found that effects were more pronounced at 15 Hz than at 5 Hz, suggesting a dose-response relationship in frequency. This is consistent with the broader WBV literature where protocol parameters significantly influence outcomes.

Frequently Asked Questions

What does research say about WBV and blood pressure?

The 2016 Chen et al. experimental study in elderly adults reported that a 6-week WBVV programme was associated with reduced blood pressure and improved arterial stiffness parameters. The 2021 Liu et al. study found that low-frequency LBV (15 Hz) was associated with reduced peripheral vascular tone and accelerated heart rate recovery after exercise. These findings are consistent with WBV having a positive effect on cardiovascular parameters, though optimal protocols and long-term effects require further study.

Has WBV been studied in relation to arterial stiffness?

Yes. The 2016 Chen et al. study specifically examined the effects of a 6-week WBVV programme on arterial stiffness parameters and blood pressure in elderly adults. Researchers reported that WBVV was associated with improved arterial stiffness markers and reduced blood pressure. Arterial stiffness (measured by pulse wave velocity) is the gold-standard non-invasive measure of vascular ageing and an independent predictor of cardiovascular events.

What is the proposed mechanism connecting WBV to cardiovascular function?

The proposed mechanism involves the mechanical stimulation of the vascular endothelium by vibration-induced shear stress. The muscle pump activation during WBV increases venous return and arterial shear rate, which activates endothelial nitric oxide synthase (eNOS) — the same enzyme activated by conventional aerobic exercise. NO production promotes vasodilation, reduces arterial stiffness, and supports blood pressure regulation. This is a proposed mechanism supported by biological plausibility and the observed outcomes in some studies.

What is the difference between WBVV and WBPA for cardiovascular research?

WBVV (Whole Body Vertical Vibration) delivers an up-and-down vertical oscillatory stimulus — the user stands or sits on a vibrating platform. WBPA (Whole Body Periodic Acceleration), delivered by the BGREEN uBed, uses horizontal rocking acceleration in a head-to-toe direction while lying down. Both generate shear stress on the endothelium, but through different mechanical motions. WBPA has been more specifically studied for direct nitric oxide production pathways. WBVV’s vascular effects are proposed to operate through a similar endothelial shear stress mechanism. See the WBPA and Nitric Oxide Research page for the WBPA-specific literature.

What are the limitations of current WBV cardiovascular research?

Key limitations include: relatively few large-scale long-term trials specifically targeting cardiovascular endpoints in older adults; heterogeneous protocols; the Liu 2021 study was in young healthy adults (limiting generalisability); and most evidence for direct NO production comes from the WBPA literature rather than WBVV specifically. Longer-duration trials with hard cardiovascular endpoints would strengthen the evidence base.

Related Topics

At Vibrahealth

BGREEN WBVV products — the uChair, uSofa, and uFit vibration plates — are wellness equipment designed to deliver vertical vibration exercise. They are not medical devices and are not intended to treat cardiovascular conditions or any medical condition. The BGREEN uBed delivers WBPA (horizontal rocking) and is designed for users who prefer or require a lying-down position. Healthcare professionals are welcome to book a complimentary demonstration at our Wellness Lounge at The Adelphi, Singapore.

For healthcare facility enquiries, visit our Eldercare Partners page.

Sources

  1. Chen YC et al. (2016). Effects of whole body vertical vibration on arterial stiffness and blood pressure in elderly. ECSS Conference Proceedings.
  2. Liu KC et al. (2021). Low-frequency vibration facilitates post-exercise cardiovascular autonomic recovery. Journal of Sports Science and Medicine, 20, 431-437. https://doi.org/10.52082/jssm.2021.431

Research Notice: Research cited on this page is independent, peer-reviewed scientific work. BGREEN and Turtlegym products are wellness and lifestyle equipment — they are not medical devices and are not intended to diagnose, treat, cure, or prevent any medical condition. Findings from independent research do not constitute claims about Vibrahealth products. Persons with health conditions should consult a qualified healthcare professional before use.